Cargando…
Non-invasive measurement of photosensitiser concentration using fluorescence differential path-length spectroscopy: validation for different liposomal formulations of m-THPC: Foscan, Foslip and Fospeg
Autores principales: | de Visscher, Sebastiaan, Witjes, Max, Kascáková, Slávka, Robinson, Dominic, Sterenborg, Henricus, Roodenburg, Jan, Amelink, Arjen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007721/ http://dx.doi.org/10.1186/1758-3284-2-S1-O46 |
Ejemplares similares
-
In vivo monitoring of Foscan-mediated photodynamic therapy in clinical head and neck procedures using optical spectroscopy
por: Kanick, Stephen, et al.
Publicado: (2010) -
Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003) -
Relationship between subcellular localisation of Foscan® and caspase activation in photosensitised MCF-7 cells
por: Marchal, S, et al.
Publicado: (2007) -
In vivo quantification of photosensitizer fluorescence in the skin-fold observation chamber using dual-wavelength excitation and NIR imaging
por: Kaščáková, Slávka, et al.
Publicado: (2011) -
Foscan® (mTHPC) photosensitized macrophage activation: enhancement of phagocytosis, nitric oxide release and tumour necrosis factor-α-mediated cytolytic activity
por: Coutier, S, et al.
Publicado: (1999)